Page last updated: 2024-10-21

3-methoxytyramine and Cholestasis, Intrahepatic

3-methoxytyramine has been researched along with Cholestasis, Intrahepatic in 1 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krähe, J1
Hauffa, BP1
Wollmann, HA1
Käser, H1

Other Studies

1 other study available for 3-methoxytyramine and Cholestasis, Intrahepatic

ArticleYear
Transient elevation of urinary catecholamine excretion and cholestatic liver disease in a neonate with hypopituitarism.
    Journal of pediatric gastroenterology and nutrition, 1992, Volume: 14, Issue:2

    Topics: Bilirubin; Catecholamines; Cholestasis, Intrahepatic; Diagnosis, Differential; Dihydroxyphenylalanin

1992